ReviewBMB reports2026
Multi-layered gene regulation by long non-coding RNAs: from chromatin to genome architecture.
Review in BMB reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Quantum molecular resonance and secretome synergistically unlocks a protective ceRNA axis in the human retinal pigment epithelium.Molecular therapy. Nucleic acids · 2026Article
- Long Non-coding RNA TLX1NB Regulates Inflammatory Response in Periodontitis by Interacting With Matrix Metalloproteinase 8.Inflammation · 2026Article
- Recent Advances (2020-2025) in Estrogen and ER-Positive Breast Cancer: Receptor Signaling, Tumor Microenvironment, Endocrine Therapy Resistance and Innovative Treatment Strategies-A Comprehensive Review.Cancer management and research · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Long non-coding RNAs (lncRNAs) are now recognized as pivotal regulators that enable the fine-tuned control of gene expression. While the functional diversity of lncRNAs challenges comprehensive understanding of their mechanisms, recent advances have revealed how these molecules coordinate epigenomic control, ranging from local chromatin regulation to large-scale nuclear organization. By scaffolding, recruiting, or antagonizing transcription factors and chromatin-modifying complexes, lncRNAs shape chromatin states, including histone modifications and DNA methylation patterns. In parallel, lncRNAs regulate three-dimensional genome architecture by modulating chromatin loops, topologically associating domains, and nuclear compartments. These regulatory mechanisms frequently operate in a coordinated manner, as exemplified by X chromosome inactivation, in which lncRNAs direct chromosome-wide silencing through combined epigenetic reprogramming and architectural remodeling. This review synthesizes current mechanistic insights into how lncRNAs integrate epigenetic modification with architectural regulation to achieve spatiotemporal gene expression, and highlights how lncRNA dysregulation contributes to human disease. We provide an integrative perspective on how lncRNAs link epigenetic programs with genome topology to control normal physiology and pathogenesis. [BMB Reports 2026; 59(2): 112-123].
Indexed as
Identifiers
41407320PMC12936598What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.